Works matching DE "FINANCE of pharmaceutical research"
Results: 19
Big Pharma's Lat Refuge.
- Published in:
- Bio-IT World, 2011, v. 10, n. 5, p. 15
- By:
- Publication type:
- Article
Perspective: Close the knowledge gap.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
WHO plans for neglected diseases are wrong.
- Published in:
- Nature, 2014, v. 506, n. 7488, p. 267, doi. 10.1038/506267a
- By:
- Publication type:
- Article
Creating value with financially adaptive clinical trials.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 8, p. 523, doi. 10.1038/nrd4682
- By:
- Publication type:
- Article
Encouraging New Uses for Old Drugs.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Work Progresses on Male Contraceptives, but Hurdles Remain.
- Published in:
- 2017
- By:
- Publication type:
- journal article
SIMULATING PHARMACEUTICAL MARKETS IN THE DEVELOPING WORLD: THE PROBLEMS WITH "PULL" FUNDING MECHANISMS.
- Published in:
- Boston University International Law Journal, 2012, v. 30, n. 1, p. 261
- By:
- Publication type:
- Article
Drug Success Rates Remain Low.
- Published in:
- Applied Clinical Trials, 2010, v. 19, n. 2, p. 14
- Publication type:
- Article
The Ethics of Pharmaceutical Research Funding: A Social Organization Approach.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Glybera's Second Act: The Curtain Rises on the High Cost of Therapy.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 2, p. 217, doi. 10.1038/mt.2014.248
- By:
- Publication type:
- Article
A Wellcome experiment in seeding drug discovery.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.
- Published in:
- Pharmaceuticals (14248247), 2016, v. 9, n. 3, p. 35, doi. 10.3390/ph9030035
- By:
- Publication type:
- Article
WHO report on drug development marred by big pharma leak.
- Published in:
- Nature Medicine, 2010, v. 16, n. 2, p. 133, doi. 10.1038/nm0210-133
- By:
- Publication type:
- Article
Would Tirofiban Have Been Shown Non-Inferior to Abciximab Had the TENACITY Trial Not Been Terminated for Financial Reasons? Would Tirofiban Have Been Shown Non-Inferior to Abciximab Had the TENACITY Trial Not Been Terminated for Financial Reasons?
- Published in:
- Journal of Interventional Cardiology, 2013, v. 26, n. 2, p. 123, doi. 10.1111/j.1540-8183.2013.12020.x
- By:
- Publication type:
- Article
Successful private-public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines.
- Published in:
- European Journal of Pediatrics, 2015, v. 174, n. 4, p. 481, doi. 10.1007/s00431-014-2398-z
- By:
- Publication type:
- Article
How the Biopharmaceutical Industry Can Navigate a Healthcare Ecosystem Increasingly Driven by Demands for Comparative Effectiveness Research.
- Published in:
- Pharmaceutical Medicine, 2011, v. 25, n. 6, p. 361, doi. 10.1007/BF03256879
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Bulletin of the World Health Organization, 2001, v. 79, n. 2, p. 175
- Publication type:
- Article
Swingeing cuts.
- Published in:
- Chemistry & Industry, 2012, v. 76, n. 11, p. 43, doi. 10.1002/cind.7611_13.x
- By:
- Publication type:
- Article
Drug Discovery over the Past Thirty Years: Why Aren't There More New Drugs?
- Published in:
- Einstein Journal of Biology & Medicine, 2013, v. 29, n. 1/2, p. 61
- By:
- Publication type:
- Article